These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 20138666

  • 1. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
    Wang C, Chen Z, Li Z, Cen J.
    Leuk Res; 2010 Aug; 34(8):1083-90. PubMed ID: 20138666
    [Abstract] [Full Text] [Related]

  • 2. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
    Lu KV, Jong KA, Rajasekaran AK, Cloughesy TF, Mischel PS.
    Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378
    [Abstract] [Full Text] [Related]

  • 3. Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for proMMP-2 generates active MMP-2.
    Nishida Y, Miyamori H, Thompson EW, Takino T, Endo Y, Sato H.
    Cancer Res; 2008 Nov 01; 68(21):9096-104. PubMed ID: 18974156
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN.
    J Pathol; 2000 Jul 01; 191(3):245-56. PubMed ID: 10878545
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C, Loher F, Zang C, Ismair MG, Petrides PE.
    Clin Cancer Res; 1999 May 01; 5(5):1115-24. PubMed ID: 10353746
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of tissue inhibitor of matrix metalloproteinases-1 confers the anti-invasive action of cisplatin on human cancer cells.
    Ramer R, Eichele K, Hinz B.
    Oncogene; 2007 Aug 23; 26(39):5822-7. PubMed ID: 17369856
    [Abstract] [Full Text] [Related]

  • 10. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
    Hu YB, Li DG, Lu HM.
    J Gene Med; 2007 Mar 23; 9(3):217-29. PubMed ID: 17351970
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Park HJ, Lee HJ, Min HY, Chung HJ, Suh ME, Park-Choo HY, Kim C, Kim HJ, Seo EK, Lee SK.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):31-6. PubMed ID: 16309669
    [Abstract] [Full Text] [Related]

  • 12. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
    Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M.
    EMBO J; 2001 Sep 03; 20(17):4782-93. PubMed ID: 11532942
    [Abstract] [Full Text] [Related]

  • 13. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y, Yeon J, Kim HJ, Lee ST.
    Biochem J; 2000 Feb 01; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells.
    Luo XH, Liao EY.
    Horm Metab Res; 2001 Jul 01; 33(7):383-8. PubMed ID: 11507673
    [Abstract] [Full Text] [Related]

  • 16. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.
    Kanayama H, Yokota K, Kurokawa Y, Murakami Y, Nishitani M, Kagawa S.
    Cancer; 1998 Apr 01; 82(7):1359-66. PubMed ID: 9529029
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.
    Parmo-Cabañas M, Molina-Ortiz I, Matías-Román S, García-Bernal D, Carvajal-Vergara X, Valle I, Pandiella A, Arroyo AG, Teixidó J.
    J Pathol; 2006 Jan 01; 208(1):108-18. PubMed ID: 16278822
    [Abstract] [Full Text] [Related]

  • 19. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.
    Park JM, Kim A, Oh JH, Chung AS.
    Carcinogenesis; 2007 Apr 01; 28(4):837-47. PubMed ID: 17071627
    [Abstract] [Full Text] [Related]

  • 20. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
    Monea S, Lehti K, Keski-Oja J, Mignatti P.
    J Cell Physiol; 2002 Aug 01; 192(2):160-70. PubMed ID: 12115722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.